A Novel Intergenic LSM14A-RET Fusion Variant in a Patient With Lung Adenocarcinoma

J Thorac Oncol. 2020 Apr;15(4):e52-e53. doi: 10.1016/j.jtho.2019.11.025.

Authors

Ye Lv¹, Feng Ling¹, Junling Zhang², Mingzhe Xiao², Weidong Mao³

Affiliations

¹ Department of Medical Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, P.R. China.
² Medical Department, 3D Medicines Inc., Shanghai, P.R. China.
³ Department of Medical Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, P.R. China. Electronic address: jysmwd@163.com.

PMID: 32216946
DOI: 10.1016/j.jtho.2019.11.025

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma of Lung / genetics
Adenocarcinoma* / genetics
Humans
Lung Neoplasms* / genetics
Oncogene Proteins, Fusion / genetics
Proto-Oncogene Proteins c-ret

Substances

Oncogene Proteins, Fusion
Proto-Oncogene Proteins c-ret
RET protein, human